drug

PF-07868489

1 story · latest Nov 2, 2026

Follow PF-07868489. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Pfizer

Timeline

Pfizer ends phase 2 extension study of PF-07868489 in pulmonary arterial hypertension

Nov 2Trial updatePF-07868489 Pfizer

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.